Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 21,502 | 20,575 | 21,461 | 20,943 | 20,899 |
| Cost of Goods | 10,590 | 10,253 | 10,652 | 10,337 | 14,188 |
| Gross Profit | 10,912 | 10,322 | 10,809 | 10,606 | 6,711 |
| Operating Expenses | 36,388 | 28,727 | 31,169 | 25,403 | 19,399 |
| Operating Income | -24,886 | -18,152 | -19,708 | -14,460 | -12,500 |
| Interest Expense | 4,250 | 4,753 | 4,529 | 4,220 | 3,655 |
| Other Income | 15 | 42 | -94 | 42 | 108 |
| Pre-tax Income | -29,121 | -22,863 | -24,331 | -18,638 | -16,047 |
| Net Income Continuous | -29,121 | -22,863 | -24,331 | -18,638 | -16,047 |
| Net Income | $-29,121 | $-22,863 | $-24,331 | $-18,638 | $-16,047 |
| EPS Basic Total Ops | -600.00 | -532.00 | -700.00 | -500.00 | -400.00 |
| EPS Basic Continuous Ops | -623.84 | -532.19 | -656.15 | -499.82 | -448.66 |
| EPS Diluted Total Ops | -600.00 | -532.00 | -700.00 | -500.00 | -400.00 |
| EPS Diluted Continuous Ops | -623.84 | -532.19 | -656.15 | -499.82 | -448.66 |
| EBITDA(a) | $-20,764 | $-17,660 | $-24,193 | $-9,032 | $-12,083 |